Clinical Trial Update: Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating the impact of emotional mimicry and oxytocin on frontotemporal dementia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontotemporal Dementia

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Frontotemporal Dementia | Phase 2 | Status: COMPLETED